Business ❯Finance ❯Corporate Finance

Pharmaceutical Industry

Eli Lilly Bristol-Myers Squibb Pfizer Pfizer Inc. Merck & Co. Vertex Pharmaceuticals Novo Nordisk Biosimilars Cardinal Health AstraZeneca Citius Pharmaceuticals Bristol Myers Squibb Johnson & Johnson

Novavax Reports Narrower Q4 Loss and Strategic Shift Away from COVID-19 Vaccine Commercialization

The biotech company plans to focus on licensing its technology and expanding its vaccine pipeline after declining sales of its COVID-19 vaccine.

Johnson & Johnson Exceeds Q4 Expectations with Strong Cancer Drug Sales

Eli Lilly Lowers 2024 Revenue Forecast as Weight-Loss Drug Sales Lag

Eli Lilly Shares Plunge After Disappointing Q3 Earnings and Sales

Cardinal Health Exceeds Q4 Estimates, Raises 2025 Profit Outlook

Eli Lilly's Q2 Earnings Surge on High Demand for Weight-Loss Drugs

Pfizer and Merck Diverge in Q2 Performance Amid Revised Forecasts

Bristol Myers Squibb Surges on Strong Q2 Performance and Raised Guidance